Long-term exposure to hypoxia inhibits tumor progression of lung cancer in rats and mice

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Yu, Lunyin ^a   Hales, Charles A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

A549 lung cancer cells; Animals; HCT116 colon cancer cells; Hypoxia; Lewis lung carcinoma; Metastasis; Tumor growth

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) ALPHA 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; ENDOTHELIAL PAS DOMAIN CONTAINING PROTEIN 1; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE PROGRESSION; CELL HYPOXIA; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LONG TERM EXPOSURE; LUNG CANCER; LUNG METASTASIS; LYMPH NODE METASTASIS; MICROVASCULATURE; MOUSE; NONHUMAN; OXYGENATION; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRATEGIC PLANNING; TISSUE TYPES; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; ANOXIA; BAGG ALBINO MOUSE; C57BL MOUSE; CELL STRAIN HCT116; DISEASE COURSE; EXPERIMENTAL NEOPLASM; GENETICS; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METABOLISM; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); NUDE RAT; PATHOLOGY; TIME; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; ANOXIA; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL HYPOXIA; CELL LINE, TUMOR; DISEASE PROGRESSION; HCT116 CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, NUDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SODIUM-POTASSIUM-EXCHANGING ATPASE; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 79961007822     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-331     Document Type: Article

References (52)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008, 58(2):71-96. 10.3322/CA.2007.0010, 18287387.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55(2):74-108. 10.3322/canjclin.55.2.74, 15761078.
3. Yang BH, Parkin DM, Cai L, Zhang ZF. Cancer burden and trends in the Asian Pacific Rim region. Asian Pac J Cancer Prev 2004, 5(2):96-117.
4. Bray F, Møller B. Predicting the future burden of cancer. Nat Rev Cancer 2006, 6(1):63-74. 10.1038/nrc1781, 16372017.
5. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60(5):277-300. 10.3322/caac.20073, 20610543.
6. Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J cancer 1955, 9(4):539-49. 10.1038/bjc.1955.55, 2073776, 13304213.
7. Toffoli S, Michiels C. Intermittent hypoxia is a key regulator of cancer cell and endothelial cell interplay in tumours. FEBS J 2008, 275(12):2991-3002. 10.1111/j.1742-4658.2008.06454.x, 18445039.
8. Brizel DM, Dodge RK, Clough RW, Dewhirst MW. Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. Radiother Oncol 1999, 53(2):113-7. 10.1016/S0167-8140(99)00102-4, 10665787.
9. Brizel DM, Sibley GS, Prosnitz LR, Scher RL, Dewhirst MW. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1997, 38(2):285-9. 10.1016/S0360-3016(97)00101-6, 9226314.
10. Rofstad EK, Sundfør K, Lyng H, Tropé CG. Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis. Br J Cancer 2000, 83(3):354-9. 10.1054/bjoc.2000.1266, 2374576, 10917551.
11. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996, 56(19):4509-15.
12. Fyles A, Milosevic M, Hedley D, Pintilie M, Levin W, Manchul L, Hill RP. Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol 2002, 20(3):680-7. 10.1200/JCO.20.3.680, 11821448.
13. Yasuda H. Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer. Nitric Oxide 2008, 19(2):205-16. 10.1016/j.niox.2008.04.026, 18503779.
14. Lu XG, Xing CG, Feng YZ, Chen J, Deng C. Clinical significance of immunohistochemical expression of hypoxia-inducible factor-1alpha as a prognostic marker in rectal adenocarcinoma. Clin Colorectal Cancer 2006, 5(5):350-3. 10.3816/CCC.2006.n.005, 16512994.
15. Brahimi-Horn MC, Chiche J, Pouysségur J. Hypoxia and cancer. J Mol Med 2007, 85(12):1301-7. 10.1007/s00109-007-0281-3, 18026916.
16. Chan N, Milosevic M, Bristow RG. Tumor hypoxia, DNA repair and prostate cancer progression: new targets and new therapies. Future Oncol 2007, 3(3):329-41. 10.2217/14796694.3.3.329, 17547528.
17. Zhang Y, Li M, Yao Q, Chen C. Recent advances in tumor hypoxia: tumor progression, molecular mechanisms, and therapeutic implications. Med Sci Monit 2007, 13(10):RA175-80.
18. Chaudary N, Hill RP. Hypoxia and metastasis. Clin Cancer Res 2007, 13(7):1947-9. 10.1158/1078-0432.CCR-06-2971, 17404073.
19. Lunt SJ, Chaudary N, Hill RP. The tumor microenvironment and metastatic disease. Clin Exp Metastasis 2009, 26(1):19-34. 10.1007/s10585-008-9182-2, 18543068.
20. Brown JM. Tumor hypoxia in cancer therapy. Methods Enzymol 2007, 435:297-321.
21. Greijer AE, van der Wall E. The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol 2004, 57(10):1009-14. 10.1136/jcp.2003.015032, 1770458, 15452150.
22. Rofstad EK, Rasmussen H, Galappathi K, Mathiesen B, Nilsen K, Graff BA. Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor. Cancer Res 2002, 62(6):1847-53.
23. Rofstad EK, Galappathi K, Mathiesen B, Ruud EB. Fluctuating and diffusion-limited hypoxia in hypoxia-induced metastasis. Clin Cancer Res 2007, 13(7):1971-8. 10.1158/1078-0432.CCR-06-1967, 17360973.
24. Zhang L, Hill RP. Hypoxia enhances metastatic efficiency in HT1080 fibrosarcoma cells by increasing cell survival in lungs, not cell adhesion and invasion. Cancer Res 2007, 67(16):7789-97. 10.1158/0008-5472.CAN-06-4221, 17699784.
25. Büchler P, Reber HA, Lavey RS, Tomlinson J, Büchler MW, Friess H, Hines OJ. Tumor hypoxia correlates with metastatic tumor growth of pancreatic cancer in an orthotopic murine model. J Surg Res 2004, 120(2):295-303. 10.1016/j.jss.2004.02.014, 15234226.
26. Cairns RA, Kalliomaki T, Hill RP. Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. Cancer Res 2001, 61(24):8903-8.
27. Cairns RA, Hill RP. A fluorescent orthotopic model of metastatic cervical carcinoma. Clin Exp Metastasis 2004, 21(3):275-81.
28. Cairns RA, Hill RP. Acute hypoxia enhances spontaneous lymph node metastasis in an orthotopic murine model of human cervical carcinoma. Cancer Res 2004, 64(6):2054-61. 10.1158/0008-5472.CAN-03-3196, 15026343.
29. Terraneo L, Bianciardi P, Caretti A, Ronchi R, Samaja M. Chronic systemic hypoxia promotes LNCaP prostate cancer growth in vivo. Prostate 2010, 70(11):1243-54. 10.1002/pros.21160, 20333700.
30. Kalliomäki TM, McCallum G, Lunt SJ, Wells PG, Hill RP. Analysis of the effects of exposure to acute hypoxia on oxidative lesions and tumour progression in a transgenic mouse breast cancer model. BMC Cancer 2008, 8:151. 10.1186/1471-2407-8-151, 2427038, 18507854.
31. Coleman CN, Mitchell JB, Camphausen K. Tumor hypoxia: chicken, egg, or a piece of the farm?. J Clin Oncol 2002, 20(3):610-5.
32. Yu L, Quinn DA, Garg HG, Hales CA. Cyclin-dependent kinase inhibitor p27Kip1, but not p21WAF1/Cip1, is required for inhibition of hypoxia-induced pulmonary hypertension and remodeling by heparin in mice. Circ Res 2005, 97(9):937-45. 10.1161/01.RES.0000188211.83193.1a, 16195480.
33. Yu L, Quinn DA, Garg HG, Hales CA. Deficiency of the NHE1 gene prevents hypoxia-induced pulmonary hypertension and vascular remodeling. Am J Respir Crit Care Med 2008, 177(11):1276-84. 10.1164/rccm.200710-1522OC, 2408441, 18310478.
34. Onn A, Isobe T, Itasaka S, Wu W, O'Reilly MS, Ki Hong W, Fidler IJ, Herbst RS. Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice. Clin Cancer Res 2003, 9:5532-5539.
35. Jacoby JJ, Erez B, Korshunova MV, Williams RR, Furutani K, Takahashi O, Kirkpatrick L, Lippman SM, Powis G, O'Reilly MS, Herbst RS. Treatment with HIF-1alpha antagonist PX-478 inhibits progression and spread of orthotopic human small cell lung cancer and lung adenocarcinoma in mice. J Thorac Oncol 2010, 5(7):940-9.
36. Yu L, Tian H, Shu Q, Liu M. Inhibition of DDC, an inhibitor of superoxide dismutase, on metastasis of Lewis lung cancer. Chin J Cancer 1993, 12(4):337-38.
37. Yu L, Garg HG, Li B, Linhardt RJ, Hales CA. Antitumor effect of butanoylated heparin with low anticoagulant activity on lung cancer growth in mice and rats. Curr Cancer Drug Targets 2010, 10(2):229-41. 10.2174/156800910791054176, 20201787.
38. Yu L, Quinn DA, Garg HG, Hales CA. Gene expression of cyclin-dependent kinase inhibitors and effect of heparin on their expression in mice with hypoxia-induced pulmonary hypertension. Biochem Biophys Res Commun 2006, 345(4):1565-72. 10.1016/j.bbrc.2006.05.060, 16729969.
39. Yu L, Blackburn GL, Zhou JR. Genistein and daidzein downregulate prostate androgen-regulated transcript-1 (PART-1) gene expression induced by dihydrotestosterone in human prostate LNCaP cancer cells. J Nutr 2003, 133(2):389-92.
40. Kulish OP, Galkina KA. Effect of high-altitude hypoxia on effectiveness of tumor chemotherapy. Bulletin Exper Biol Med 1983, 95(2):201-203.
41. Mairbäurl H, Wodopia R, Eckes S, Schulz S, Bärtsch P. Impairment of cation transport in A549 cells and rat alveolar epithelial cells by hypoxia. Am J Physiol 1997, 273(4 Pt 1):L797-806.
42. Wodopia R, Ko HS, Billian J, Wiesner R, Bärtsch P, Mairbäurl H. Hypoxia decreases proteins involved in epithelial electrolyte transport in A549 cells and rat lung. Am J Physiol Lung Cell Mol Physiol 2000, 279(6):L1110-9.
43. Heerlein K, Schulze A, Hotz L, Bärtsch P, Mairbäurl H. Hypoxia decreases cellular ATP demand and inhibits mitochondrial respiration of a549 cells. Am J Respir Cell Mol Biol 2005, 32(1):44-51.
44. Gusarova GA, Dada LA, Kelly AM, Brodie C, Witters LA, Chandel NS, Sznajder JI. Alpha1-AMP-activated protein kinase regulates hypoxia-induced Na,K-ATPase endocytosis via direct phosphorylation of protein kinase C zeta. Mol Cell Biol 2009, 29(13):3455-64. 10.1128/MCB.00054-09, 2698765, 19380482.
45. Güney S, Schuler A, Ott A, Höschele S, Zügel S, Baloglu E, Bärtsch P, Mairbäurl H. Dexamethasone prevents transport inhibition by hypoxia in rat lung and alveolar epithelial cells by stimulating activity and expression of Na+-K+-ATPase and epithelial Na+ channels. Am J Physiol Lung cell Mol Physiol 2007, 293(5):L1332-8. 10.1152/ajplung.00338.2006, 17873005.
46. Mijatovic T, Roland I, Van Quaquebeke E, Nilsson B, Mathieu A, Van Vynckt F, Darro F, Blanco G, Facchini V, Kiss R. The alpha1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers. J Pathol 2007, 212(2):170-9. 10.1002/path.2172, 17471453.
47. Xu ZW, Wang FM, Gao MJ, Chen XY, Hu WL, Xu RC. Targeting the Na(+)/K(+)-ATPase alpha1 subunit of hepatoma HepG2 cell line to induce apoptosis and cell cycle arresting. Biol Pharm Bull 2010, 33(5):743-51. 10.1248/bpb.33.743, 20460749.
48. Volm M, Koomagi R. Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer. Anticancer Res 2000, 20:1527-1533.
49. Beasley NJ, Leek R, Alam M, Turley H, Cox GJ, Gatter K, Millard P, Fuggle S, Harris AL. Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res 2002, 62:2493-2497.
50. Fiorenzo P, Mongiardi MP, Dimitri D, Cozzolino M, Ferri A, Montano N, Trevisi G, Maira G, Battistini L, Falchetti ML, Levi A, Pallini R. HIF1-positive and HIF1-negative glioblastoma cells compete in vitro but cooperate in tumor growth in vivo. Int J Oncol 2010, 36(4):785-91.
51. Imamura T, Kikuchi H, Herraiz MT, Park DY, Mizukami Y, Mino-Kenduson M, Lynch MP, Rueda BR, Benita Y, Xavier RJ, Chung DC. HIF-1alpha and HIF-2alpha have divergent roles in colon cancer. Int J cancer 2009, 124(4):763-71. 10.1002/ijc.24032, 2682346, 19030186.
52. Zhou G, Dada LA, Chandel NS, Iwai K, Lecuona E, Ciechanover A, Sznajder JI. Hypoxia-mediated Na-K-ATPase degradation requires von Hippel Lindau protein. FASEB J 2008, 22(5):1335-42.